Key Points
- SiBone CEO Laura Francis sold 38,006 shares at an average price of $20.05, generating $762,020.30. Her remaining ownership fell 9.11% to 379,256 shares.
- SiBone shares opened at $19.47, down 1.1%, while the company reported quarterly revenue of $56.01 million and an adjusted loss of $0.09 per share, beating analyst expectations.
- Wall Street maintains a favorable outlook, with six Buy ratings and one Sell rating and a consensus price target of $24.50; institutional investors own 98.11% of the stock.
SiBone (NASDAQ:SIBN - Get Free Report) CEO Laura Francis sold 38,006 shares of the stock in a transaction that occurred on Monday, October 12th. The stock was sold at an average price of $20.05, for a total value of $762,020.30. Following the sale, the chief executive officer owned 379,256 shares in the company, valued at approximately $7,604,082.80. This trade represents a 9.11% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Laura Francis also recently made the following trade(s):
- On Monday, August 24th, Laura Francis sold 25,972 shares of SiBone stock. The shares were sold at an average price of $20.12, for a total value of $522,556.64.
- On Friday, August 21st, Laura Francis sold 3,923 shares of SiBone stock. The shares were sold at an average price of $20.02, for a total value of $78,538.46.
- On Thursday, August 20th, Laura Francis sold 51,884 shares of SiBone stock. The stock was sold at an average price of $19.46, for a total transaction of $1,009,662.64.
SiBone Stock Down 1.1%
Shares of NASDAQ:SIBN opened at $19.47 on Thursday. SiBone has a 12 month low of $11.48 and a 12 month high of $21.89. The company's 50-day moving average price is $18.92 and its two-hundred day moving average price is $16.47. The company has a quick ratio of 7.55, a current ratio of 9.15 and a debt-to-equity ratio of 0.20. The firm has a market cap of $863.48 million, a P/E ratio of -57.26 and a beta of 0.66.
SiBone (NASDAQ:SIBN - Get Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.06. SiBone had a negative net margin of 6.85% and a negative return on equity of 8.23%. The firm had revenue of $56.01 million during the quarter, compared to analysts' expectations of $55.34 million. As a group, research analysts forecast that SiBone will post -0.40 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on SIBN. UBS Group boosted their price objective on shares of SiBone from $24.00 to $25.00 and gave the stock a "buy" rating in a research report on Tuesday, August 4th. Truist Financial increased their price objective on SiBone from $23.00 to $25.00 and gave the company a "buy" rating in a research report on Wednesday. Weiss Ratings upgraded SiBone from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Thursday, August 20th. Finally, TD Cowen lifted their target price on SiBone from $18.00 to $20.00 and gave the company a "buy" rating in a research note on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $24.50.
View Our Latest Stock Report on SIBN
Institutional Investors Weigh In On SiBone
Institutional investors have recently made changes to their positions in the stock. First Light Asset Management LLC increased its holdings in SiBone by 51.8% in the second quarter. First Light Asset Management LLC now owns 8,127,985 shares of the company's stock valued at $132,649,000 after purchasing an additional 2,774,795 shares during the last quarter. Granahan Investment Management LLC boosted its holdings in SiBone by 97.6% during the first quarter. Granahan Investment Management LLC now owns 1,739,097 shares of the company's stock worth $21,965,000 after buying an additional 858,942 shares during the last quarter. Paradigm Capital Management Inc. NY boosted its holdings in SiBone by 113.3% during the first quarter. Paradigm Capital Management Inc. NY now owns 1,126,500 shares of the company's stock worth $14,228,000 after buying an additional 598,300 shares during the last quarter. Renaissance Technologies LLC grew its position in shares of SiBone by 101.6% during the 1st quarter. Renaissance Technologies LLC now owns 472,619 shares of the company's stock worth $5,969,000 after buying an additional 238,219 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in shares of SiBone by 41.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 618,939 shares of the company's stock worth $7,816,000 after buying an additional 182,465 shares during the period. 98.11% of the stock is owned by institutional investors and hedge funds.
SiBone Company Profile
(
Get Free Report)
SI-BONE, Inc is a medical device company focused on developing and commercializing products for the surgical treatment of disorders affecting the sacroiliac joint, which connects the spine to the pelvis. The company's technology is intended to support minimally invasive procedures for patients with sacroiliac joint dysfunction and related conditions.
Its product portfolio includes the iFuse Implant System, a family of triangular titanium implants designed to stabilize and fuse the sacroiliac joint.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
